William Meury Insider Trading
Get free email notifications about insider trading for William Meury.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William Meury. William Meury is a EVP - Sales and Marketing in Forest Laboratories, LLC ($FRX) and a SVP - Marketing in Forest Laboratories, LLC ($FRX) and a in Syndax Pharmaceuticals Inc ($SNDX) and a Chief Commercial Officer in Allergan plc ($AGN) and a Chief Communication Officer in Allergan plc ($AGN) and a EVP & Chief Commercial Officer in Allergan plc ($AGN) and a See Remarks in Allergan plc ($AGN).
Address: C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK 10022 NY
Companies in which William Meury is an Insider
Allergan plc
Trading Symbol: AGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Meury: EVP & Chief Commercial Officer, Chief Commercial Officer, Chief Communication Officer, See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2020
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Forest Laboratories, LLC
Trading Symbol: FRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Meury: EVP - Sales and Marketing, SVP - Marketing
Holdings: 0 shares
Latest Transaction: Jul 03 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Trading Symbol: SNDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Meury:
Holdings: 16,000 shares
Current Value: $139,040
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of William Meury
Sentiment: All, AGN, FRX, SNDX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Meury William | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 21,621 | 1,734,004 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 21,621 | 1,734,004 | 0 |